Philip James Wealth Mangement LLC Invests $5.25 Million in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Philip James Wealth Mangement LLC bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 586,121 shares of the pharmacy operator's stock, valued at approximately $5,252,000. Philip James Wealth Mangement LLC owned approximately 0.07% of Walgreens Boots Alliance as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Keudell Morrison Wealth Management bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $107,000. Deseret Mutual Benefit Administrators lifted its stake in Walgreens Boots Alliance by 14.1% in the third quarter. Deseret Mutual Benefit Administrators now owns 16,268 shares of the pharmacy operator's stock valued at $146,000 after buying an additional 2,010 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Walgreens Boots Alliance by 2.9% during the third quarter. Principal Financial Group Inc. now owns 886,144 shares of the pharmacy operator's stock worth $7,940,000 after acquiring an additional 24,974 shares during the last quarter. Cozad Asset Management Inc. acquired a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth about $116,000. Finally, Centennial Wealth Advisory LLC lifted its position in Walgreens Boots Alliance by 24.2% in the 3rd quarter. Centennial Wealth Advisory LLC now owns 17,113 shares of the pharmacy operator's stock valued at $153,000 after purchasing an additional 3,337 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

WBA has been the topic of several analyst reports. Bank of America dropped their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating on the stock in a research note on Wednesday, September 4th. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a research report on Friday, October 11th. Evercore ISI increased their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an "in-line" rating in a report on Wednesday, October 16th. TD Cowen cut their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating for the company in a research report on Tuesday, October 22nd. Finally, UBS Group boosted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a "neutral" rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $12.88.

Walgreens Boots Alliance Stock Down 2.2 %

Shares of WBA stock traded down $0.20 on Friday, hitting $9.07. The company's stock had a trading volume of 21,031,006 shares, compared to its average volume of 17,306,301. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The stock has a market capitalization of $7.84 billion, a price-to-earnings ratio of -0.91, a P/E/G ratio of 1.21 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.22 and a fifty-two week high of $27.05. The firm's fifty day moving average price is $9.18 and its 200-day moving average price is $12.21.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter in the prior year, the company posted $0.67 EPS. The firm's revenue was up 5.9% on a year-over-year basis. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.03%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance's payout ratio is -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.